CI

At a glance

ClinicalIndex Comparison Record
N/ANot Yet Recruiting· 100 target
Drug / intervention
Bloat +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07370740
NCT07370740N/ANot Yet Recruiting

A Randomized, Double-blind, Placebo-controlled, Parallel Clinical Trial to Investigate the Safety and Efficacy of Bloat on Gas and Bloating in Healthy Women

Arrae·interventional·Posted Jan 27, 2026·Updated Jan 27, 2026

In Brief

A clinical study evaluating Bloat and Placebo for Bloating and 2 related conditions. Not yet recruiting, targeting 100 participants across 1 site.

Detailed Summary

The goal of this clinical trial is to investigate the safety and efficacy of Bloat on gas and bloating in healthy women. The main question it aims to answer is what is the change in postprandial gas and bloating from pre-dose at t = 60 mins post-dose between Bloat and placebo, as assessed by Gas and Bloating Likert scale at screening/baseline. Participants will be asked to consume one dose of Bloat or Placebo and answer questionnaires on gas and bloating.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada
CollaboratorsKGK Science Inc.

Timeline

N/ANot Yet RecruitingOverdue
2026
First PostedJan 27, 2026
Enrollment StartMay 1, 2026
Primary CompletionJul 1, 2026
TodayJul 1, 2026
Enrollment to primary: 2 monthsPosted 5 months ago

Interventions

Bloatdietary

Participants will be instructed to take one dose (2 capsules) 30 minutes after consumption of the entire standardized meal during the screening/baseline clinic visit.

Placeboother

Participants will be instructed to take one dose (2 capsules) 30 minutes after consumption of the entire standardized meal during the screening/baseline clinic visit